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Introduction
About 80% of patients with cluster headache (CH) have
a history of cigarette smoking [1]; a common genetic
basis between CH and smoking has been suggested by
the identification of a gene cluster on chromosome
15q25, encoding for neuronal acetylcholine receptor
subunits a3, a5 and b4 (CHRNA5-CHRNA3-CHRNB4).
Receptors containing the a5 subunit contribute to nico-
tine withdrawal symptoms and anxiety modulation [2,3].
Aim
To identify rare variants with a possible role in the etiology
of CH and nicotine addiction, we investigated the genetic
variants into the locus CHRNA5-CHRNA3 using the
blood of CH patients and compared it with the blood of
control patients (case-control association study).
Materials and methods
We enrolled 65 patients with CH, of which 53 men and
12 women; male to female ratio=4.4:1. In the sample there
were 48 active smokers, 12 former smokers and 5 patients
whom had never smoked. CH patients were, respectively,
divided into two groups: 54 with episodic and 11 with
chronic form. We analyzed three single nucleotide poly-
morphisms (SNPs) known to be associated with nicotine
addiction (rs16969968 and rs6495306 localized on
CHRNA5 gene; rs578776 localized on CHRNA3 gene)
in CH patients and in a control group consisting of
263 individuals that were comparable for age, smoking
status and geographic origin. The analysis of rare variants
of the genes was performed by sequencing of the coding
portion of the gene and 5’-untranslated region (5’UTR)
with the Sanger method. The sequence and genomic orga-
nization were obtained from the University of California
Santa Cruz (UCSC) genome browser (http://genome.ucsc.
edu/). PLINK (http://pngu.mgh.harvard.edu/purcell/plink/)
was used for the statistical analysis of the data.
Results
The analysis of the sequences did not evidence new muta-
tions with a functional effect on the development of dis-
ease. However, as regards the three polymorphisms
selected, the comparison of the allelic frequencies in CH
patients and in healthy smokers, highlighted a slight but
statistically significant with regards to the SNP rs578776
localized on 3’-untranslated region (3’-UTR). The A allele,
protective in the risk of developing nicotine addiction and
obtained by the replacement of the aspartic acid with
asparagine in position 398, is less expressed (p = 0.038) in
CH patients.
Discussion
CH patients seem to have a stronger genetic predispo-
sition to develop smoke dependence. Probably, the
excessive intake of nicotine could be associated with an
up-regulation of pineal nicotinic receptor a3b4 [4], and
this could trigger a dysfunction of melatonin release
linked to the CH’s chrono-biological profile.
Written informed consent to publication was obtained
from the patient(s).
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